In this episode of The Fellow on Call: The Heme/Onc Podcast: In an effort to lay the groundwork for further discussion about DLBCL, the hosts temporarily shift their focus to the fundamentals of chimeric antigen receptor (CAR) T-cell therapy, bispecific T-cell engagers (BiTE), and autologous transplants. They talk about what CAR T cells are, how they’re created, the side effects of a CAR-T-related cytokine storm, how BiTE therapy differs from CAR-T, and much more.
This podcast originally appeared on The Fellow on Call: The Heme/Onc Podcast.